Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<IPO>CSPC PHARMA Subsidiary INNOVATION (300765.SZ) Files IPO Application to HKEX
Recommend 3 Positive 10 Negative 2 |
||||
|
||||
|
CSPC PHARMA (01093.HK) announced that INNOVATION (300765.SZ), in which the company holds a 75% stake through its wholly-owned subsidiary, NBP Pharmaceutical, submitted its listing application to the Hong Kong Stock Exchange yesterday (10th), with CITIC Securities acting as the sole sponsor. For the first seven months ending July 2025, INNOVATION recorded revenue of approximately RMB1.241 billion, up 8.7% YoY. During the period, the company turned from profit to loss, recording a net loss of approximately RMB9.181 million, compared to a profit of RMB117 million in the same period last year. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
